Pricing Log in Create free account
Monday 2 November 2026 Export CLX’s income statement to Excel — free account

The Clorox Company

CLX Consumer Defensive Household & Personal Products

The Clorox Company’s revenue for fiscal 2026 (year ended June 2026) was $6.7 billion, down 5.41% from fiscal 2025.

Revenue
+33.3%
EPS
+113.9%
Free cash flow
+11.4%
Total debt
+60.2%

Quarter to September 2026, against a year earlier

90.05 2.05 +2.33%
Market cap
$10.6B
P/E
16.2×
Fwd P/E
15.6×
Dividend yield
5.53%
F-score
4/9
Altman Z
2.10
Beneish M
−2.43
Dividend safety
26/100
Overview Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Filings

Revenue by segment Fiscal 2023

  • Health and Wellness
  • Household
  • Lifestyle
  • International
  • Other, not broken out

Every year since 2010 →

Insider Decisions last twelve months

Bought, $m 0.43
Trades a month
Jan 26 Apr 26 Jul 26 Oct 26
Buy — — — — — 1 — — — — — —
Sell — — — — — — — — — — — —
Insider Ownership 1.18%

Capital & Financial Ratios $m

Size
Market Cap 10,640.00
Revenue ttm 7,196.00
Net income ttm 692.00
Free cash flow ttm 453.00
Net debt Q 3,798.00
Valuation
P/E 16.20
Forward P/E 15.60
Price / sales 1.52
Forward P/S Powerpack
Price / FCF 24.18
Price / book 90.51 (above 6: high)
Financial health
Current ratio Q 0.65 (below 1: weak)
Debt / equity Q 32.91 (above 2: weak)
Interest coverage Q 0.00
Growth
Revenue growth Q +33.31% (above 0%: growing)
Operating income growth Q −39.29% (below 0%: shrinking)
EPS, this year +2.95%
EPS, next year A +7.44%
Revenue, next year A +13.54% (at or above 10%: strong)
EPS, past 5 yrs −2.93% (below 0%: weak)
EPS, next 5 yrs A +5.08%

Green and red mark values outside typical ranges; (Q) is the latest quarter, (A) analysts’ estimates. How we judge →

Valuation vs history

EV/Sales, ten years
EV/Sales is 2.0×, against a ten-year median of 3.1×; over the ten years it ranged from 1.9× in 2026 to 4.7× in 2020.
P/E against its own 10 years 3.38%
10-year low 10-year high
P/S against its own 10 years 1.10%
10-year low 10-year high
P/B against its own 10 years 85.32%
10-year low 10-year high
EV/Sales against its own 10 years 2.68%
10-year low 10-year high
EV/FCF against its own 10 years 79.41%
10-year low 10-year high

Dividends raised every year since 2017

Yield
5.53%
Annual rate
4.98
Payout ratio
89.6%
Growth, 2017–26
+4.75%/yr
  1. 3.28 ’17
  2. 3.72 ’18 +13%
  3. 4.04 ’19 +9%
  4. 4.34 ’20 +7%
  5. 4.54 ’21 +5%
  6. 4.68 ’22 +3%
  7. 4.76 ’23 +2%
  8. 4.84 ’24 +2%
  9. 4.92 ’25 +2%
  10. 4.98 ’26 +1%
paid Powerpack

Assets vs Liabilities $m

2024 2025 2026 Q'26
Cash 202 167 143 184
Receivables 695 821 791 745
Inventory 637 523 777 774
Other — — — —
1,622 1,608 1,824 1,931
2024 2025 2026 Q'26
Payables 1,486 1,828 1,600 1,689
ST’ Debt — — 1 —
Other — — — —
1,574 1,919 2,773 2,954

Compound Annual Growth %

10y 5y 3y
Sales 1.55% (1.75%) (3.11%)
Cash Flow (2.37%) (13.67%) (19.15%)
Earnings (0.98%) (3.73%) 57.94%
Book Value (1.63%) (15.70%) (13.40%)

Earnings Trends EPS, adjusted, against the consensus

Q4 FY26 Estimate 1.64 Actual 1.66

Earnings per share against the consensus, by quarter
Quarter Estimate Reported Result
Q1 FY26 0.78 0.85 Beat by 0.07
Q2 FY26 1.43 1.39 Miss by 0.04
Q3 FY26 1.48 1.64 Beat by 0.16
Q4 FY26 1.64 1.66 Beat by 0.02
Q1 FY27 0.97 — Reports 2 November 2026

EPS $

Sep Dec Mar Jun Year
’26 1.39 — — — —
’26 0.65 1.29 1.54 1.34 4.81
’25 0.80 1.54 1.50 2.68 6.52
’24 0.17 0.75 (0.41) 1.73 2.25
’23 0.68 0.80 (1.71) 1.42 1.20
’22 1.14 0.56 1.21 0.81 3.73
’21 3.22 2.03 (0.49) 0.78 5.58
Fiscal quarters ending in the months shown.

Revenue $m

Sep Dec Mar Jun Year
’26 1,905 — — — —
’26 1,429 1,673 1,670 1,948 6,720
’25 1,762 1,686 1,668 1,988 7,104
’24 1,386 1,990 1,814 1,903 7,093
’23 1,740 1,715 1,915 2,019 7,389
’22 1,806 1,691 1,809 1,801 7,107
’21 1,916 1,842 1,781 1,802 7,341
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Sep Dec Mar Jun Year
’26 143 — — — —
’26 93 311 (122) 330 612
’25 221 180 286 294 981
’24 20 153 182 340 695
’23 178 209 341 430 1,158
’22 41 181 229 335 786
’21 383 246 264 383 1,276
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Sep Dec Mar Jun Year
’26 105 — — — —
’26 57 269 (165) 244 405
’25 182 127 233 219 761
’24 (4) 101 127 259 483
’23 132 167 285 346 930
’22 (11) 124 166 256 535
’21 314 164 183 284 945
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

3.2
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to June

Ten-year view Analyst estimates Powerpack
Group Line 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 TTM Sep ’26 Trend 10 yrs 2027e 2028e 2029e Next 3/yr
Income, $m
Income, $m Revenue 5,973 6,124 6,214 6,721 7,341 7,107 7,389 7,093 7,104 6,720 7,196 +1.3% 7,630 7,818 8,072 +6.3%
Gross margin, % 44.72 43.68 43.90 45.57 43.58 35.81 39.36 42.97 45.23 42.32 41.94 (2.4) pt
EBT 1,033 1,054 1,024 1,185 900 607 238 398 1,078 791 891 (2.9%)
EBT margin, % 17.29 17.21 16.48 17.63 12.26 8.54 3.22 5.61 15.17 11.77 12.38 (5.5) pt
Net income 701 823 820 939 719 471 161 292 824 601 692 (1.7%)
Per share, $
Per share, $ Revenue 46.32 47.37 48.65 53.41 58.46 57.73 59.79 57.12 57.51 55.18 59.17 +2.0%
Earnings 5.43 6.37 6.42 7.46 5.66 3.75 1.21 2.26 6.56 4.82 5.56 (1.3%)
Cash flow 6.71 7.55 7.77 12.29 10.16 6.38 9.37 5.60 7.94 5.03 5.44 (3.2%)
Capex (1.79) (1.50) (1.61) (2.02) (2.64) (2.04) (1.84) (1.71) (1.78) (1.70) (1.72) (0.6%)
Free cash flow 4.92 6.05 6.15 10.27 7.53 4.35 7.52 3.89 6.16 3.33 3.72 (4.3%)
Book value 4.20 5.62 4.38 7.22 4.71 5.92 3.14 3.96 3.90 2.07 0.99 (7.6%)
Shares, m 129 129 128 126 126 123 124 124 124 122 122 (0.6%)
Valuation, ×
Valuation, × P/E 24.49 20.93 23.73 29.41 31.90 37.70 130.36 59.66 18.30 19.80 16.20 39.6
P/S 2.88 2.82 3.14 4.11 3.08 2.44 2.66 2.35 2.09 1.73 1.52 2.7
P/B 31.70 23.78 34.92 30.40 38.16 23.81 50.66 33.88 30.77 46.12 90.51 34.4
EV/Sales 3.11 3.24 3.56 4.40 3.41 2.81 2.97 2.73 2.48 2.30 2.05 3.1
EV/FCF 29.27 25.34 28.11 22.89 26.51 37.32 23.56 40.13 23.11 38.18 32.56 29.4
Cash, $m
Cash, $m Operating cash flow 865 976 992 1,546 1,276 786 1,158 695 981 612 662 (3.8%)
Capex (231) (194) (206) (254) (331) (251) (228) (212) (220) (207) (209) (1.2%)
Free cash flow 634 782 786 1,292 945 535 930 483 761 405 453 (4.9%)
Balance, $m
Balance, $m Working capital (295) 111 (135) 602 (227) (59) (89) 48 (311) (949) (1,023) +13.9%
Net debt 1,373 2,352 2,572 1,975 2,465 2,612 2,256 2,279 2,317 3,839 3,798 +12.1%
Shareholders’ equity 542 726 559 908 592 729 388 492 482 252 121 (8.2%)
Returns, %
Returns, % ROA 15.44 17.09 16.12 16.58 11.32 7.40 2.46 4.79 14.32 8.79 10.13 (6.6) pt
ROIC 36.78 23.07 22.44 27.62 18.95 14.03 9.64 11.55 24.12 13.95 0.00 (22.8) pt
ROE 167.10 129.81 127.63 128.02 94.67 69.95 26.68 63.64 166.32 159.95 522.78 (7.2) pt
People
People Employees 8,100 8,700 8,800 8,800 9,000 9,000 8,700 8,000 7,600 9,200 — +1.4%
Revenue/emp, $m 0.74 0.70 0.71 0.76 0.82 0.79 0.85 0.89 0.93 0.73 — (0.1%)
Negative figures in brackets.
estimates

All 10 years →

Fiscal years to Jun 2026 · latest quarter Sep 2026 · fundamentals updated 2 Nov 2026

Where the money comes from and where it goes Fiscal 2023

Fiscal 2023: revenue by segment, and margins
Health and Wellness 2,532 34.27%
Household 2,098 28.39%
Lifestyle 1,338 18.11%
International 1,181 15.98%
Other, not broken out 240 3.25%
Gross margin 39.36%
Operating margin 5.52%
Pre-tax margin 3.22%

Revenue by segment since 2010

The Clorox Company vs peers in Household & Personal Products (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
EL The Estee Lauder Companies Inc. $39.6B 214× 37.4× +6.33% (above 0%: growing) +78.81% (above 0%: growing) +7.87% (above 0%: growing) 75.46% (1.08%) Compare
KVUE Kenvue Inc. $37.1B 22.2× 20.3× +3.02% (above 0%: growing) +9.09% (above 0%: growing) +17.07% (above 0%: growing) 58.18% 17.67% Compare
KMB Kimberly-Clark Corporation $35.9B 18.4× 16.9× +0.62% (above 0%: growing) −32.03% (below 0%: shrinking) −4.79% (below 0%: shrinking) 38.27% 15.11% Compare
CHD Church & Dwight Co., Inc. $25.4B 34.4× 28.9× +1.57% (above 0%: growing) +10.26% (above 0%: growing) +23.33% (above 0%: growing) 45.35% 18.07% Compare
CLX The Clorox Company $10.6B 18.3× 15.6× −2.01% (below 0%: shrinking) −50.37% (below 0%: shrinking) +11.42% (above 0%: growing) 41.27% 13.24%
ELF e.l.f. Beauty $6.6B 112× 59.3× +35.52% (above 0%: growing) +91.53% (above 0%: growing) +447.39% (above 0%: growing) 83.20% 21.37% Compare
IPAR Interparfums, Inc. $3.7B 22.3× 23.8× +2.13% (above 0%: growing) −5.00% (below 0%: shrinking) +1,031.52% (above 0%: growing) 65.54% 14.35% Compare
COTY Coty $3.0B — (loss-making) 31.7× +1.34% (above 0%: growing) n/m +20.86% (above 0%: growing) 60.88% (3.36%) Compare
NWL Newell Brands Inc. $2.2B — (loss-making) 9.4× +3.05% (above 0%: growing) n/m +84.62% (above 0%: growing) 40.72% 14.19% Compare
Median of peers $16.0B 28.3× 26.4× +2.58% +9.68% +22.10% 59.53% 14.73%

All 31 Household & Personal Products stocks →

From the latest earnings call

Updated

  • CEO Linda Rendle said Clorox expects muted category growth and continued value-seeking behavior, while investing in products, packaging and targeted pricing.
  • CFO Luc Bellet said fiscal 2027 inflation would exceed $200 million, with the impact more pronounced in the first half.

Largest institutional holders 13F, quarter to 30 June 2026

Held by institutions 84.98%
Held by the ten largest 45.39%
Holder Shares Stake Change
Vanguard 14.77m 12.21% +54.25k
BlackRock 10.04m 8.31% −127.45k
State Street 8.43m 6.97% +177.95k
Invesco 6.01m 4.97% +1.15m
Geode Capital Management 3.27m 2.70% +36.87k
UBS 3.19m 2.64% +1.04m
VanEck 2.97m 2.46% −245.43k
Morgan Stanley 2.25m 1.86% −469.23k
Millennium Management 2.07m 1.71% +1.38m
Bank of America 1.88m 1.56% +477.93k
13F filings for the quarter to 30 June 2026: long positions in US-listed shares reported by managers with $100m or more, ~45 days after the quarter.

Pay and ownership Proxy statement filed 7 October 2026

Chief executive’s pay

Year Total pay Actually paid $100 invested
2026 14.00m 2.64m 62.92
2025 13.33m 10.45m 75.71
2024 12.69m 6.23m 83.30
2023 11.65m 19.41m 93.86
2022 8.53m 7.09m 80.59

Ownership

Directors and executive officers, together less than 1%
BlackRock, Inc. 8.23%
Vanguard Capital Management LLC 7.35%
State Street Corporation State Street Financial Center 6.95%
Total pay is as the Summary Compensation Table states it; actually paid revalues the year’s share awards at its end, as the SEC’s pay-versus-performance rule asks. $100 invested is what $100 in the company’s shares at the start of the earliest year shown was worth at each year’s end. Ownership is the proxy’s own table: the directors and officers as a group, and every holder of 5% or more. Read the proxy statement

The Clorox Company (CLX) Latest News

2 Nov

Impact 3 · · PR Newswire

29 Oct

Impact 4 · · Simply Wall St.
Impact 4 · · Simply Wall St.
Impact 4 · · PR Newswire
Impact 3 · · Simply Wall St.

27 Oct

Impact 4 · · 24/7 Wall St.

26 Oct

Impact 3 · · The Motley Fool
Impact 3 · · Zacks

21 Oct

Impact 4 · · 24/7 Wall St.

20 Oct

Impact 3 · · 24/7 Wall St.

19 Oct

Impact 4 · · TIKR

17 Oct

Impact 4 · · Insider Monkey

16 Oct

Impact 4 · · Simply Wall St.

15 Oct

Impact 3 · · Simply Wall St.
Impact 3 · · Simply Wall St.
Impact 3 · · Barchart

14 Oct

Impact 4 · · TIKR

12 Oct

Impact 4 · · TIKR
Impact 3 · · StockStory
Impact 3 · · The Motley Fool

6 Oct

Impact 4 · · Simply Wall St.
Impact 4 · · Zacks

5 Oct

Impact 3 · · Insider Monkey

3 Oct

Impact 3 · · Insider Monkey

1 Oct

Impact 4 · · Zacks
Impact 3 · · Zacks

28 Sep

Impact 4 · · PR Newswire
Impact 4 · · 24/7 Wall St.
Impact 3 · · Simply Wall St.

24 Sep

Impact 3 · · PR Newswire

CLX metrics, ten years each

stockrow.com/CLX · Data as of Nov 2, 2026 · For information only; not investment advice. · © 2026 stockrow.com